Longeveron INC Form 4 insider transactions
NASDAQ
LGVN
Longeveron INCDirector and Chief Scientific Officer Joshua Hare reports acquisition of shares and stock options in Longeveron Inc.
NASDAQ
LGVN
Longeveron INCDirector Baluch Khoso reports acquisition of 23,500 shares of Longeveron Inc. through restricted stock units.
NASDAQ
LGVN
Longeveron INCUrsula Ungaro, a director at Longeveron Inc., received 23,500 shares of Class A Common Stock on August 15, 2024, as part of a time-based vesting Restricted Stock Unit (RSU) award.
NASDAQ
LGVN
Longeveron INCDirector Rock Soffer was awarded 23,500 Restricted Stock Units (RSUs) in Longeveron Inc. on August 15, 2024.
NASDAQ
LGVN
Longeveron INCForm 4: Longeveron Director Neil E. Hare Acquires 23,500 Shares of Class A Common Stock Through RSU Award
Director Neil E. Hare reports acquisition of 23,500 shares of Longeveron Inc. Class A Common Stock through a Restricted Stock Unit (RSU) award.
NASDAQ
LGVN
Longeveron INCDirector Roger Joseph Hajjar acquired 16,000 shares of Longeveron Inc. common stock on July 2, 2024, as part of a restricted stock unit grant.
NASDAQ
LGVN
Longeveron INCDirector Neha J. Motwani acquired 16,000 shares of Longeveron Inc. Class A Common Stock on July 2, 2024, as part of a restricted stock unit grant.
NASDAQ
LGVN
Longeveron INCLisa Locklear, CFO of Longeveron Inc., disposed of 357 shares of Class A Common Stock on July 1, 2024, to satisfy tax obligations.
NASDAQ
LGVN
Longeveron INCDirector Khoso Baluch reports a transaction involving the withholding of shares to cover tax obligations related to a restricted stock unit vesting.
NASDAQ
LGVN
Longeveron INCPaul T. Lehr, General Counsel and Secretary of Longeveron Inc., reports disposition of shares to cover tax obligations related to vesting of restricted stock units.
NASDAQ
LGVN
Longeveron INCDirector Richard N. Kender acquired 16,000 shares of Longeveron Inc. Class A Common Stock on May 10, 2024, through a grant of restricted stock units.
NASDAQ
LGVN
Longeveron INCLisa Locklear, CFO of Longeveron Inc., reports the disposal of 410 shares of Class A Common Stock to cover tax obligations following a one-for-ten reverse stock split.
NASDAQ
LGVN
Longeveron INCNataliya Agafonova, Chief Medical Officer of Longeveron Inc., reports disposition of shares to cover tax obligations following a reverse stock split.
NASDAQ
LGVN
Longeveron INCDirector and Chief Scientific Officer Joshua Hare reports acquisition of Longeveron Inc. shares and warrants, along with a transfer of shares to an ex-spouse.
NASDAQ
LGVN
Longeveron INCLongeveron's CEO, Mohamed Hashad, purchased 10,638 shares of Class A Common Stock and warrants at $2.35 on April 11, 2024.
NASDAQ
LGVN
Longeveron INCDirector Soffer Rock acquired additional shares and warrants of Longeveron Inc. (LGVN) on April 10 and 11, 2024, increasing their beneficial ownership.
NASDAQ
LGVN
Longeveron INCCEO Mohamed Wa'el Ahmed Hashad reports acquisition and disposal of Longeveron Inc. shares on March 12, 2024, according to a Form 4 filing.